Company news
18.12.09
Lab21 acquires US nanotechnology company and establishes Lab21 Inc. in South Carolina →
26.11.09
Lab21 acquires personalised medicine diagnostic services business →
17.11.09
Lab21 launches new high sensitivity immunodiagnostic system for CMV antibody detection →
15.09.09
Lab21 expands oncology portfolio with 5-FU personalised chemotherapy management service →
21.07.09
Lab21 announces publication of syphilis diagnostic patent →
Investor relations
Introduction
Lab21 is a global provider of state-of-the-art diagnostic products and services, supporting healthcare and environmental markets. Established in 2005 with the vision of providing 21st century diagnostics the Company’s main objective is to protect the health of people and the environment. We believe that ‘prevention is better than cure’ and we aim to provide information that helps to protect from the health problems of tomorrow.

